Anti program death-1/anti program death-ligand 1 in digestive cancers

Por de Guillebon, Eléonore, Roussille, Pauline, Frouin, Eric, Tougeron, David
Publicado no World J Gastrointest Oncol (2015)

Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma

Por Combe, Pierre, de Guillebon, Eleonore, Thibault, Constance, Granier, Clémence, Tartour, Eric, Oudard, Stéphane
Publicado no Oncoimmunology (2015)

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer

Por Granier, Clemence, De Guillebon, Eleonore, Blanc, Charlotte, Roussel, Helene, Badoual, Cecile, Colin, Elia, Saldmann, Antonin, Gey, Alain, Oudard, Stephane, Tartour, Eric
Publicado no ESMO Open (2017)

Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8(+) T cells

Por Hasmim, Meriem, Badoual, Cécile, Vielh, Philippe, Drusch, Françoise, Marty, Virginie, Laplanche, Agnès, de Oliveira Diniz, Mariana, Roussel, Hélène, De Guillebon, Eléonore, Oudard, Stéphane, Hans, Stéphane, Tartour, Eric, Chouaib, Salem
Publicado em 2013

Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy

Por Roussel, Hélène, De Guillebon, Eléonore, Biard, Lucie, Mandavit, Marion, Gibault, Laure, Fabre, Elisabeth, Antoine, Martine, Hofman, Paul, Beau-Faller, Michèle, Blons, Hélène, Danel, Claire, Barthes, Françoise Le Pimpec, Gey, Alain, Granier, Clémence, Wislez, Marie, Laurent-Puig, Pierre, Oudard, Stéphane, Bruneval, Patrick, Badoual, Cécile, Cadranel, Jacques, Tartour, Eric
Publicado no Oncoimmunology (2017)